Badanie trajektorii: przewidywanie zdrowia kardiometabolicznego u nastolatków i młodych dorosłych na podstawie sprawności dzieciństwa, snu i diety (Trajectory)

Adolescents (13 to 17 years) and young adults (18 to 21 years) who previously participated in the Arkansas Active Kids study (clinicaltrials.gov #NCT03221673; IRB #206217) and the MI Energy study (clinicaltrials.gov #NCT04427462; IRB #260376).

Inclusion Criteria:

• Ages 13 to 21 years.
• Boys or girls.
• All ethnicities.
• All BMIs.
• Previous participation in the Arkansas Active Kids study and the MI Energy study.
• Participants who previously agreed to be contacted for future research at ACNC.
• Participants who agree to the use of their previously collected information and samples from the AAK or MI Energy studies for the follow-up study.

Exclusion Criteria:

• Asthma that requires daily use of inhalers to keep symptoms under control.
• Asthma that requires use of rescue inhalers (e.g., albuterol) >2 days per week.
• Exercise-induced asthma.
• Autism spectrum disorder (e.g., Autistic disorder, Rett disorder, Asperger disorder, childhood disintegrative disorder, pervasive developmental disorder not otherwise specified (PDD-NOS).
• Neurological disorders (e.g. epilepsy or seizures).
• Cancer.
• Hormonal disease (e.g., hypothyroidism and growth hormone deficiency).
• Autoimmune diseases (e.g., lupus, thyroiditis, juvenile idiopathic arthritis).
• Bleeding disorders (e.g., hemophilia).
• Chronic infections (e.g., HIV, hepatitis B, hepatitis C).
• Other pre-existing medical conditions or medications as determined by the investigators to affect the outcomes of interest.
• Pregnancy (verbal assessment).